These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3871341

  • 21. Kinetics of protein synthesis inactivation in human T-lymphocytes by selective monoclonal antibody-ricin conjugates.
    Leonard JE, Wang QC, Kaplan NO, Royston I.
    Cancer Res; 1985 Nov; 45(11 Pt 1):5263-9. PubMed ID: 3876881
    [Abstract] [Full Text] [Related]

  • 22. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF, Griffin JD, Kessler SW, Cutting MA, Knight RD, Blattler WA, Lambert JM, Wright DG.
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [Abstract] [Full Text] [Related]

  • 23. Different susceptibilities of normal T cells and T cell lines to immunotoxins.
    Preijers FW, Tax WJ, Wessels JM, Capel PJ, De Witte T, Haanen C.
    Scand J Immunol; 1988 May; 27(5):533-40. PubMed ID: 3259720
    [Abstract] [Full Text] [Related]

  • 24. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells.
    Uckun FM, Gajl-Peczalska K, Meyers DE, Ramsay NC, Kersey JH, Colvin M, Vallera DA.
    Blood; 1987 Jan; 69(1):361-6. PubMed ID: 3098325
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
    Filipovich AH, Vallera DA, Youle RJ, Haake R, Blazar BR, Arthur D, Neville DM, Ramsay NK, McGlave P, Kersey JH.
    Transplantation; 1987 Jul; 44(1):62-9. PubMed ID: 3299923
    [Abstract] [Full Text] [Related]

  • 29. Cytotoxic effect of anti-Mr 67,000 protein immunotoxins on human tumors in a nude mouse model.
    Weil-Hillman G, Runge W, Jansen FK, Vallera DA.
    Cancer Res; 1985 Mar; 45(3):1328-36. PubMed ID: 3971376
    [Abstract] [Full Text] [Related]

  • 30. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M, Bergamaschi G, Dezza L, D'Uva R, Ponchio L, Rosti V, Ascari E.
    Cancer Res; 1991 Jan 15; 51(2):536-41. PubMed ID: 1985771
    [Abstract] [Full Text] [Related]

  • 31. Mouse L1210V leukemia as a model to analyse efficiency of leukemic cell elimination by immunotoxin, antibody and complement, and cytostatic agents.
    Paprocka M, Wiedlocha A, Radzikowski C.
    In Vivo; 1990 Jan 15; 4(3):209-13. PubMed ID: 2133264
    [Abstract] [Full Text] [Related]

  • 32. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA, Knowles RW, Burns MJ, Broxmeyer HE, Lu L, Lee HM, Kawahata RT, Scannon PJ, Dupont B.
    J Immunol; 1984 Jul 15; 133(1):137-46. PubMed ID: 6609971
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow.
    Tondini C, Pap SA, Hayes DF, Elias AD, Kufe DW.
    Cancer Res; 1990 Feb 15; 50(4):1170-5. PubMed ID: 2404589
    [Abstract] [Full Text] [Related]

  • 34. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
    Ravel S, Casellas P.
    Eur J Biochem; 1990 Sep 11; 192(2):469-73. PubMed ID: 2209602
    [Abstract] [Full Text] [Related]

  • 35. Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.
    Uckun FM, Ramakrishnan S, Houston LL.
    J Immunol; 1985 Mar 11; 134(3):2010-6. PubMed ID: 3855433
    [Abstract] [Full Text] [Related]

  • 36. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM, Stong RC, Youle RJ, Vallera DA.
    J Immunol; 1985 May 11; 134(5):3504-15. PubMed ID: 3884712
    [Abstract] [Full Text] [Related]

  • 37. Human T-cell antigens defined by monoclonal antibodies. Absence of T65 on committed myeloid and erythroid progenitors.
    Taetle R, Royston I.
    Blood; 1980 Nov 11; 56(5):943-6. PubMed ID: 6968603
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Increased efficacy in selective elimination of leukemic cell line clonogenic cells by a combination of monoclonal antibodies BA-1, BA-2, BA-3 + complement and mafosfamid (ASTA Z 7557).
    LeBien TW, Anderson JM, Vallera DA, Uckun FM.
    Leuk Res; 1986 Nov 11; 10(2):139-43. PubMed ID: 3951251
    [Abstract] [Full Text] [Related]

  • 40. Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.
    Vallera DA, Quinones RR, Azemove SM, Soderling CC.
    Transplantation; 1984 Apr 11; 37(4):387-92. PubMed ID: 6231750
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.